Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Methotrexate (MTX) & Sarilumab is approved by both the FDA and EMA for the treatment of moderate to severe rheumatoid arthritis (RA) in adults who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs) like Methotrexate or cannot tolerate them. Clinical studies, including the MOBILITY Phase III study, showed that Sarilumab plus Methotrexate provides significant and sustained improvements in RA disease activity, patient-reported outcomes, physical function,…